South African Press Association - June 15, 2004
"The problem we have now is some of the cross-border traders who are importing ARVs and selling them to people without a prescription, and this is dangerous," Dr Christine Chakanyuka, Zimbabwe's spokesperson for health, reportedly said.
She said the trade was dangerous, as patients required constant contact with health professionals to ensure the drugs were working and caused no serious side effects.
The drugs were available on prescription in Zimbabwe, but were expensive with the cheapest combination costing about Z$300 000 monthly (about R370).
According to media reports illegal traders were smuggling the drugs from countries including South Africa, Botswana and Namibia, where the drugs were more readily available than Zimbabwe.
Dr Andrew Jamieson, South African Airways Netcare Travel Clinics director, said the trade could be expected in South Africa as most patients who were poor may be tempted to sell the drugs provided by the government.
Jamieson said the trade would result in complexities as the "stop and start" treatment was likely to create resistance to the drug.
"With this in mind, special packaging has been devised in South Africa to minimise on-sale of freely dispensed ARVs," said Jamieson.
He said drugs provided to patients in Uganda were also sold on the black market to drug stores in the country.
040615
SA040603
Copyright © 2004 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .